The study drew on a large community screening cohort in Guangzhou involving 30,012 individuals who underwent serological testing for viral hepatitis markers, including hepatitis B surface antigen and hepatitis C virus antibodies. From this effort, 1,676 people tested positive for viral hepatitis. After excluding 516 participants with incomplete baseline questionnaires, the final analytical sample comprised 1,160 individuals. The researchers then divided these screening-positive patients into two groups based on a single, clinically meaningful behavior: whether they returned to certified viral hepatitis treatment facilities to receive standardized follow-up after learning of their positive result. Those who did, 285 cases or 24.57 percent of the sample, formed the observation group, while the 875 cases who did not return, 75.43 percent, formed the control group. The stark imbalance between the two groups is itself a finding worth pausing on, because it quantifies the scale of the linkage problem that hepatitis programs face even in a well-resourced urban setting with accessible treatment facilities.

To measure knowledge, all participants completed a self-developed six-item standardized questionnaire covering prevention and treatment of viral hepatitis. A total score of at least three points, meaning more than half of the six-item scale, was defined as adequate hepatitis knowledge. The team then applied a battery of statistical techniques to probe the relationship between knowledge and adherence: subgroup comparisons, stratified chi-squared analysis, multivariate linear regression, binary logistic regression with interaction terms, and one-to-three propensity score matching to adjust for baseline differences between the groups. This methodological arsenal matters because simple comparisons between people who seek care and those who do not are notoriously vulnerable to confounding. Patients who return for follow-up may differ systematically in age, education, disease awareness, or family experience with liver disease, and any of those differences could masquerade as a knowledge effect if not properly controlled.

The headline result was negative, and the authors are explicit about it. Across all screening-positive patients, no significant overall correlation was observed between hepatitis knowledge level and follow-up adherence. The knowledge qualification rate was 53.33 percent in the observation group versus 52.11 percent in the control group, a difference that was statistically indistinguishable with a P value of 0.720. In other words, roughly half of the patients in both groups possessed adequate knowledge about hepatitis prevention and treatment, and knowing more did not predict who would come back for care. This null finding challenges a widespread assumption in public health practice, namely that health education campaigns which raise awareness will translate into improved health-seeking behavior. The Health Belief Model, which underpins much of health behavior theory, posits that perceived susceptibility and severity drive action, but this study suggests that knowledge alone, without the motivational scaffolding of personal or family experience, may be insufficient to move patients from awareness to action.

When the researchers examined demographic and clinical characteristics, most variables showed no significant differences between the adherent and non-adherent groups. Gender, ethnicity, marital status, education, occupation, and hepatitis type all failed to distinguish the two groups in significance testing. Two variables did stand out: age, with a P value of 0.016, and family history of liver disease, with a P value below 0.001. Propensity score assessment using standardized mean differences demonstrated adequate balance for age after matching, at 0.022, but family history showed severe baseline imbalance, with a standardized mean difference of 0.718. This imbalance is a critical technical detail, because it means that patients with a known family history of liver disease were dramatically overrepresented among those who returned for follow-up, and any analysis that fails to account for this difference risks drawing distorted conclusions about what drives adherence.

The stratified analysis revealed the study’s most striking pattern. Among participants with a definite family history of liver disease, the knowledge qualification rate in the observation group was significantly higher than in the control group, suggesting that for these patients, knowledge and adherence traveled together. Among participants with unknown family history, the pattern reversed dramatically: only 6.58 percent of the adherent observation group had adequate knowledge, compared with 41.45 percent of the non-adherent control group. This reversed gap is one of the most intriguing findings in the paper, hinting that patients without a known family history who nonetheless adhere to follow-up may be doing so for reasons unrelated to knowledge, while those with unknown family history who possess knowledge may still fail to act on it. Subgroup analyses restricted to the observation group further showed that family history, with a P value of 0.001, and educational attainment, with a P value of 0.016, were both associated with hepatitis knowledge qualification status, with participants who had a confirmed family history of liver disease and college-level or higher education exhibiting the highest qualification rates.

Yet the formal statistical test for moderation complicates the story. In multivariate logistic regression analysis, the interaction term between family history and total knowledge score lacked statistical significance, with an odds ratio of 0.953 and a P value of 0.729. This means that, strictly speaking, the global analysis does not support family history as a formal statistical moderator of the knowledge-adherence relationship. However, stratified analyses revealed divergent associations within subgroups: the positive association between knowledge score and follow-up compliance was detected only among patients with a definite family history of liver disease, with an odds ratio of 1.118 and a P value of 0.015. For every one-point increase in knowledge score, the odds of follow-up compliance rose by roughly 12 percent in this subgroup, while no such relationship existed in the rest of the population. The authors are careful to frame this as subgroup heterogeneity rather than confirmed moderation, and they explicitly call for further multi-center longitudinal studies and randomized controlled trials to validate the subgroup findings and evaluate stratified intervention effects.

The practical implications reach well beyond Guangzhou. The authors conclude that universal health education alone cannot improve follow-up compliance, a conclusion that should give pause to program designers who rely on broadcast-style awareness campaigns to close the screening-to-treatment cascade. Instead, they advocate targeted strategies, including risk-stratified health education based on family history and integrated screening-treatment linkage with case management, as the appropriate tools for grassroots hepatitis prevention. This aligns with a broader shift in global hepatitis elimination strategy, championed by the World Health Organization, toward simplification and decentralization of care, in which every person who screens positive is actively accompanied into evaluation and treatment rather than simply handed information and left to navigate the system alone. Case management, in which a designated worker tracks and supports each positive patient, directly addresses the 75 percent attrition observed in this cohort.

Several limitations deserve attention when weighing these findings. The cross-sectional design captures a single moment in time and cannot establish whether low knowledge causes poor adherence or whether both reflect deeper structural barriers such as cost, distance, work obligations, or stigma. The knowledge instrument was self-developed rather than a validated external scale, and the severe baseline imbalance in family history, despite propensity score matching, means residual confounding cannot be excluded. The observation group was also relatively small at 285 participants, which limits statistical power for interaction testing, and interaction analyses are notoriously underpowered in general. Still, the study’s scale, with more than 30,000 community members screened and over 1,100 positive patients analyzed, and its rigorous multi-method statistical approach make it a valuable contribution. As countries pursue the 2030 elimination targets for viral hepatitis, the message from Guangzhou is clear: information is necessary but not sufficient, and the patients who most need to act on what they know may be precisely those for whom knowledge carries no personal urgency until programs make follow-up effortless, personal, and connected to their own family story of liver disease.

Subject of Research: The relationship between hepatitis knowledge, family history, education, and follow-up adherence among community screening-positive viral hepatitis patients in Guangzhou, China

Article Title: Family history and education moderate adherence and knowledge in viral hepatitis patients: a cross-sectional study in Guangzhou, China

Article References: Huang, Z., Li, B., Lu, A., Tan, Y., Lin, L., Liu, S., Lin, G., Ning, Q., Liu, J., Liang, H., Du, Z., Li, J., Guan, Y., & Tang, X. (2026). Family history and education moderate adherence and knowledge in viral hepatitis patients: a cross-sectional study in Guangzhou, China. Virology Journal. https://doi.org/10.1186/s12985-026-03273-4

Image Credits: AI Generated

DOI: 10.1186/s12985-026-03273-4

Keywords: viral hepatitis, hepatitis B, hepatitis C, follow-up adherence, health knowledge, family history, health education, screening-treatment linkage, cross-sectional study, Guangzhou, hepatocellular carcinoma, cirrhosis

The study drew on the STAARS cohort, the Studying Autism and ADHD Risk in Siblings project, recruited through the Birkbeck Centre for Brain and Cognitive Development. Families were enrolled if they had a first-degree relative with a clinical diagnosis of autism, a clinical or probable research diagnosis of ADHD, or if they had typically developing older children and no first-degree relatives with either condition. The final sample comprised 79 infants with an elevated likelihood of autism, 31 with an elevated likelihood of ADHD, 21 with elevated likelihood of both conditions, and 29 with typical likelihood for neither. Each child visited the lab at five, ten and fourteen months for eye-tracking sessions, and returned for developmental and language assessments at 36 months, allowing the researchers to connect infant gaze patterns with later language outcomes.

The experimental task was elegantly simple. At each visit, infants watched pairs of ten-second silent videos of a woman’s face presented side by side on a screen. In each pair, the mouth flashed open and closed at one of three temporal frequencies: a slow one hertz, a mid-range six hertz, or a fast ten to fifteen hertz, depending on the age of the infant. The mid-frequency condition is scientifically crucial because fluent speech carries most of its energy in the theta band, roughly four to eight hertz, the rhythm at which syllables are produced. Neural oscillations in this theta range are thought to be central to how the brain segments and processes speech, and previous work has shown that even newborns show theta-frequency neural activity related to speech perception. The researchers wanted to know whether babies’ eyes are drawn to mouths moving at this language-relevant rhythm.

Gaze was recorded with a Tobii TX-300 infrared eye tracker sampling at 120 hertz while infants sat on a parent’s lap. The team computed an eye-mouth looking index, or EMI, defined as the proportion of face-directed looking time spent on the eyes relative to the eyes plus the mouth combined. An index above 0.5 signals a preference for the eyes; below 0.5, a preference for the mouth. Trials with fewer than 25 percent valid gaze samples were discarded, and the longitudinal data were analysed with generalised linear mixed models, a statistical framework well suited to the missing data and bounded proportions that characterise infant eye-tracking studies.

The developmental pattern was clear. Across the whole sample, the eye-mouth index declined significantly between five and fourteen months, meaning that as babies grew older they shifted their attention progressively away from the eyes and toward the mouth. This replicates a well-established trajectory: typically developing infants look predominantly at the eyes before about five months of age and then increasingly favour the mouth through the first year, precisely the period during which they begin to comprehend and produce their first words. Interestingly, the researchers did not observe the re-orienting back toward the eyes around twelve months that some earlier studies reported, and they note that other work has found mouth attention persisting in both monolingual and bilingual children up to age five, supporting the idea that watching a moving mouth is adaptive for language learning.

Temporal frequency also mattered. Infants looked more at the eyes relative to the mouth when watching the slow one hertz faces than when watching the six hertz, speech-like faces. In other words, mouths moving at the rhythm of syllabic speech captured more attention than slowly moving mouths, providing partial behavioural support for the idea that human infants, like rhesus monkeys in earlier work by Asif Ghazanfar and colleagues, are perceptually tuned to theta-frequency facial movement. The effect was not exclusive, however: there was no significant difference in looking between the mid-frequency and high-frequency conditions, suggesting that the tuning is not a narrow bandpass filter but perhaps reflects a broader preference shaped by arousal and stimulus salience, which the authors flag as a target for future research measuring physiological arousal.

The most striking findings concerned family history. Infants with an elevated likelihood of autism showed a significantly larger eye-mouth index than infants with typical likelihood, meaning they looked relatively more at the eyes and less at the mouth across infancy. The authors interpret this as a possible developmental delay in the usual shift from eyes to mouth, since prolonged eye preference is normally a feature of younger infants. Crucially, this effect was attenuated when there was also a family history of ADHD: the interaction between autism and ADHD familial likelihood was significant, and at fourteen months the EL-autism group showed a larger index than the EL-autism-plus-ADHD group. A family history of ADHD on its own was also associated with more eye relative to mouth looking at fourteen months, a novel result in a population that has been almost entirely neglected by the eye-tracking literature. The authors argue that future family-history studies of autism should systematically map ADHD in the family, because its presence may mask or modify the effects researchers are trying to detect, potentially explaining some of the heterogeneity in previous reports.

Language added a further layer of nuance. At fourteen months, infants who had already said their first words, as measured by an item on the Mullen Scales of Early Learning, showed a smaller concurrent eye-mouth index, that is, more mouth looking, than infants who had not yet produced words, with a medium-to-large effect. This fits the experience-dependent view of face attention: once babies begin talking, watching mouth movements may help them refine and imitate the shapes of words they hear from speakers. Yet the long-term picture was more surprising. When the researchers controlled for fourteen-month word status, higher receptive language scores at 36 months were associated with greater looking to the eyes, not the mouth, across infancy. This ran counter to the authors’ prediction and to some previous findings linking mouth preference to better later language. One interpretation, drawing on recent work by Viktorsson and colleagues, is that looking at the eyes supports gaze following and joint attention, which are themselves foundational for word learning. The takeaway, the authors suggest, is that both eyes and mouth matter: mouth looking serves emerging language skills in the moment, while eye engagement relates to the interpersonal foundations of language that come to fruition in toddlerhood.

Not every hypothesis was confirmed. There were no significant differences between likelihood groups in parent-reported comprehension or production vocabulary at fourteen months on the MacArthur-Bates Communicative Development Inventory, although girls comprehended significantly more words than boys, consistent with the broader literature on early sex differences in language. Nor did the frequency effect interact with word status, and neither expressive nor receptive language at 36 months related to infant EMI until first-word status was taken into account. The authors are candid about the limitations of their design. The silent videos isolated mouth movement in a way naturalistic speech does not, arousal was not measured, and the cohort, though prospective and well characterised, was underpowered to examine actual autism or ADHD diagnoses as outcomes. Causal conclusions are therefore off the table.

Even with those caveats, the study delivers a message that resonates well beyond specialist circles: the way a baby looks at a face is not a single fixed trait but a moving target shaped by age, by the rhythm of the face itself, by the constellation of conditions in the family, and by the child’s own blossoming language. For researchers hunting early markers of neurodevelopmental conditions, the implication is that heterogeneous findings may partly reflect unmeasured heterogeneity in the samples, particularly the under-appreciated role of familial ADHD. For parents, the study offers no cause for alarm but a fascinating window into the infant mind, revealing that from the earliest months, babies are already calibrating their gaze to the rhythms of human communication, sampling eyes and mouths in a dynamic balance that foreshadows the conversational partners they will one day become.

Subject of Research: Infant eye-tracking study of visual attention to eyes versus mouths in relation to familial autism and ADHD likelihood and language development

Article Title: Infant Attention to Eyes Versus Mouth Varies With Mouth Movement Speed, Family History of Autism and Language Development

Article References: Agyapong, M., Mason, L., Begum Ali, J., Johnson, M. H., Charman, T., Jones, E. J. H., the STAARS Team, Bazelmans, T., Dafner, L., Ersoy, M., Gliga, T., Goodwin, A., Haartsen, R., Halkola, H., Hendry, A., Holman, R., Kalwarowsky, S., Kolesnik, A., Lloyd-Fox, S., … Taylor, C. (2026). Infant Attention to Eyes Versus Mouth Varies With Mouth Movement Speed, Family History of Autism and Language Development. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-026-07516-9

Image Credits: AI Generated

DOI: 10.1007/s10803-026-07516-9

Keywords: autism, ADHD, infancy, eye-tracking, language development, visual attention, face scanning, theta frequency, family history, longitudinal study, social attention, developmental psychology

The figure is likely to draw attention because it sits at the high end of the range reported in the literature on thyroid cancer in Graves’ disease, where estimates have varied widely depending on the population studied, the screening intensity applied before surgery, and the pathological methods used to examine removed glands. The authors of the new study are careful to note that their cohort consisted exclusively of patients selected for surgery, a group that is not representative of everyone living with Graves’ disease. Surgical selection bias of this kind can inflate apparent cancer prevalence, because patients chosen for thyroidectomy often have larger glands, compressive symptoms, suspicious nodules, or poorly controlled disease. Even with that caveat, the sheer proportion of tumors uncovered in the specimen analysis underscores how frequently cancer can coexist with an autoimmune, hyperfunctioning thyroid.

Histologically, the picture was dominated by one subtype. Classic papillary thyroid carcinoma accounted for 80.9 percent of the malignancies detected, making it by far the most common cancer type in the cohort. Papillary carcinoma is the predominant form of thyroid cancer worldwide, and its strong representation among patients with Graves’ disease is consistent with the broader epidemiology of the disease. The study’s authors describe the tumors found as predominantly low-grade, meaning that even though cancer was common in this surgical series, the lesions were largely of the indolent variety that typically carries an excellent prognosis when detected and treated. This distinction matters enormously for clinical interpretation: a high prevalence of low-grade papillary carcinoma in surgically removed glands does not translate directly into a high rate of life-threatening cancer in the general Graves’ population.

One of the most provocative findings concerns the tumors that no one saw coming. Seven patients in the study had incidental tumors despite no preoperative nodule detection, meaning that imaging and clinical examination before surgery had failed to reveal any focal lesion, yet pathology of the removed gland revealed carcinoma nonetheless. Incidental thyroid cancers of this kind are a well-recognized phenomenon in endocrine surgery, and their frequency in this cohort highlights a persistent diagnostic blind spot. Nodules embedded within a diffusely hyperactive, often enlarged Graves’ gland can be difficult to distinguish on ultrasound, and the autoimmune background of the gland can obscure the architectural clues that normally raise suspicion. For clinicians, the message is that a clean preoperative ultrasound in a patient with Graves’ disease does not entirely exclude the presence of malignancy.

To move beyond simple prevalence counting, the research team systematically evaluated clinical, biochemical, ultrasonographic, and pathological variables, then applied both univariable and multivariable logistic regression analyses to identify which factors independently predicted the presence of thyroid carcinoma. In the univariable analysis, two variables emerged as significantly associated with malignancy. The first was older age, with an odds ratio of 1.05 per year of age (95 percent confidence interval 1.02 to 1.09, p less than 0.001), indicating a modest but highly consistent increase in cancer odds with each additional year of life. The second was a family history of thyroid cancer, which carried an odds ratio of 5.53 (95 percent confidence interval 1.39 to 21.98, p equal to 0.015), a more than fivefold elevation in risk that stands out as the single strongest predictor identified in the study.

When the investigators refined the analysis with multivariable modeling, which adjusts for the influence of overlapping variables, both findings held firm. Age remained an independent predictor with an odds ratio of 1.06 (p less than 0.001), and family history retained its strong association with an odds ratio of 5.75 (p equal to 0.019). The stability of these two factors across both analytical approaches lends them credibility as genuine signals rather than statistical artifacts. Just as informative is the list of variables that failed to predict cancer. Sex, body mass index, smoking status, levels of thyroid-stimulating hormone receptor antibodies (TRAb), thyroid function tests, thyroid volume, and disease duration all showed no significant association with malignancy risk in this cohort.

That negative result is scientifically meaningful. TRAb, the autoantibody that drives the hyperthyroidism of Graves’ disease by stimulating the thyroid-stimulating hormone receptor, is the biochemical hallmark of the condition, and some researchers have hypothesized that the same chronic stimulation might promote tumor development. The new data suggest otherwise, at least within the limits of this study: the intensity of autoimmune activity, as reflected by antibody levels and thyroid hormone measurements, did not distinguish patients with cancer from those without. Instead, the traditional clinical risk factors recognized across thyroid cancer epidemiology, namely advancing age and a familial predisposition, proved more strongly associated with malignancy than any measure of Graves’ disease activity itself. The authors interpret this as evidence that conventional risk stratification tools may remain applicable to patients with Graves’ disease, even as the autoimmune context complicates the diagnostic landscape.

The practical implications for patient care are nuanced. On one hand, the identification of older age and family history as independent predictors offers clinicians a simple, low-cost way to heighten vigilance: a patient with Graves’ disease who is older or who reports thyroid cancer in close relatives may warrant particularly careful ultrasound surveillance and a lower threshold for further evaluation of nodules. On the other hand, the study’s design imposes important limits on how far its conclusions can be generalized. The authors themselves caution that the retrospective design, the potential for surgical selection bias, and the relatively small sample size of 134 patients all argue for cautious interpretation. A prevalence of 35.1 percent among surgical patients cannot be extrapolated to the millions of people with Graves’ disease who are managed medically and never undergo thyroidectomy.

Retrospective cohort studies of this kind occupy an important middle ground in clinical research. They cannot establish causation, and they inherit the biases of the clinical decisions that shaped the original cohort, but they can generate hypotheses and quantify associations in real-world populations that would be difficult or unethical to assemble prospectively. In this case, the dataset provides one of the more detailed recent portraits of how cancer and Graves’ disease intersect within a single surgical practice, combining biochemical profiles, imaging findings, and full pathological examination of excised glands. The systematic evaluation of variables ranging from smoking status to antibody titers gives the analysis a breadth that simpler case series often lack, and the use of multivariable regression helps separate independent signals from confounded ones.

For the broader endocrine community, the study reopens a question that has simmered for decades: does the hyperdynamic, antibody-stimulated environment of Graves’ disease create fertile ground for malignant transformation, or is the apparent excess of cancer simply a reflection of intensified surveillance and surgery? The new findings lean toward the latter interpretation, since biochemical markers of disease activity showed no relationship with cancer risk while classical demographic and familial factors did. At the same time, the substantial burden of incidental tumors found at pathology serves as a reminder that the gland removed from a Graves’ patient deserves meticulous examination, regardless of what preoperative imaging suggested. As the authors emphasize, larger prospective studies will be needed to confirm these associations and to determine whether age and family history can be incorporated into formal surveillance guidelines for the growing population of patients living with Graves’ disease.

Subject of Research: Prevalence and clinical predictors of differentiated thyroid carcinoma in patients with Graves' disease undergoing thyroidectomy

Article Title: Thyroid carcinoma in Graves’ disease: a retrospective analysis of prevalence, histological subtypes, and clinical predictors

Article References: Thyroid carcinoma in Graves’ disease: a retrospective analysis of prevalence, histological subtypes, and clinical predictors. (n.d.). https://doi.org/10.1186/s12902-026-02413-9

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02413-9

Keywords: Graves' disease, thyroid carcinoma, papillary thyroid carcinoma, thyroidectomy, thyroid nodules, TRAb, hyperthyroidism, retrospective cohort study, endocrine cancer, family history, incidental tumors, logistic regression

The research team recruited 123 adult volunteers between the ages of 30 and 60 and stratified them into three groups according to body mass index: 37 participants of normal weight, 44 who were overweight, and 42 living with obesity. Beyond the standard sociodemographic variables that often accompany obesity research, including age, sex, smoking status, exercise habits, and profession, the investigators took a battery of anthropometric measurements. These included body mass index itself, the waist-hip ratio, and the waist-to-height ratio, three metrics that together capture both general adiposity and the central fat distribution that is considered particularly hazardous for cardiometabolic health. Awareness was assessed with a validated obesity awareness scale, an instrument previously adapted and tested for reliability in Turkish populations.

The central result was a null finding with a twist. When the researchers correlated the overall obesity awareness scores with the anthropometric measurements, they found no statistically meaningful relationship. People with larger waists, higher waist-to-height ratios, or greater body mass were not systematically more, or less, aware of obesity as a health issue than their leaner counterparts. The anthropometric metrics did, however, correlate strongly with one another, which is expected given that they all index body composition and fat distribution. In other words, the measurements behaved as measurements should, but they simply did not track what participants knew or believed about obesity.

The twist emerged when the team examined the subscales of the awareness instrument. Within one awareness subscale, the overweight group scored significantly higher than the group with obesity, a difference that reached statistical significance at p = 0.005. This pattern is intriguing because it suggests that awareness is not a simple monotonic function of body size. One plausible interpretation, consistent with a broader literature on interoception and weight, is that people living with obesity may experience a degree of disengagement from weight-related health information, whether through normalization of their body size over time, through the psychological burden of internalized weight stigma, or through repeated exposure to messaging that fails to resonate. The authors are careful not to overinterpret a single subscale in a cross-sectional sample, but the directional difference is difficult to dismiss entirely.

To test whether the apparent null relationship between body size and awareness might be masking confounding, the researchers turned to multivariable regression analysis. After adjusting for baseline sociodemographic confounders, body mass index showed no independent association with overall obesity awareness whatsoever, with a p-value of 0.928. This is about as clean a null result as epidemiology produces. Whatever drives a person’s understanding of obesity, it is not, in this sample, the number on the scale or the ratio derived from it. The regression framework is important because it rules out the possibility that the raw correlation was obscured by age, sex, or other demographic factors that travel with both body size and health knowledge.

What did predict awareness were social and occupational circumstances. The presence of a family member with obesity was significantly associated with obesity awareness, at p = 0.025, and occupational status was an even stronger predictor, at p = 0.002. These two findings, taken together, sketch a picture in which awareness is a socially transmitted and structurally conditioned quantity. Living alongside a relative with obesity may provide direct, lived exposure to the condition, its management, and its consequences, effectively functioning as an informal education channel. Occupation, meanwhile, likely proxies a cluster of influences including educational attainment, health literacy, access to workplace wellness resources, physical demands of the job, and the socioeconomic conditions that shape both diet and opportunities for physical activity.

The study arrives at a moment when the scientific community is rethinking how obesity itself should be defined. A recent Lancet Diabetes and Endocrinology Commission has argued for a more clinically grounded definition of obesity that moves beyond body mass index alone, recognizing that BMI, while convenient, conflates fat mass with lean mass and says little about how adiposity affects organ function. The present findings add a psychological dimension to that debate. If awareness of obesity is disconnected from the anthropometric markers that clinicians rely on, then screening strategies that assume patients will recognize their own risk status may be built on sand. A person can carry substantial central adiposity, reflected in an elevated waist-to-height ratio, and still not perceive themselves as being at risk.

This disconnect between objective measurement and subjective awareness has been flagged in earlier work. Studies of healthcare workers have documented gaps between the prevalence of overweight in that population and the level of concern it generates, and research on adolescents has pointed to parental factors as significant correlates of obesity awareness in younger age groups. The interoception literature offers a mechanistic thread: systematic reviews and meta-analyses have examined whether the ability to perceive internal bodily signals relates to body mass, with mixed but suggestive results. If the perception of one’s own body is imperfect, then awareness of a slowly developing condition like obesity, which accumulates over years without acute symptoms, may be particularly prone to drift from reality.

The global context sharpens the stakes. The Global Burden of Disease Study 2021 analyzed 88 risk factors across 204 countries and territories, and pooled analyses of population-representative studies covering 222 million children, adolescents, and adults have documented relentless worldwide increases in overweight and obesity from 1990 to 2022. Against that backdrop, awareness is often treated as the first link in the behavior-change chain: people must recognize a problem before they seek to solve it. If that first link is forged not by the tape measure but by family dinner tables and workplace environments, then interventions that rely solely on distributing anthropometric screening results may be insufficient. Public health messaging may need to be embedded in the social settings where awareness actually takes root.

As with all cross-sectional research, the study has limits that the authors acknowledge implicitly through their design choices. A sample of 123 volunteers cannot establish causation, and it remains possible that awareness influences behavior, which in turn influences body size, in feedback loops that a single time point cannot disentangle. The use of a Turkish-validated awareness scale means the findings are most directly applicable to the population studied, though the sociocultural mechanisms they point to are unlikely to be unique to any one country. Still, the core message is clear and actionable: in this sample, obesity awareness did not correlate with objective anthropometric measures, but it did travel with family history and occupational status. Understanding obesity, it seems, is learned at home and at work, not measured at the waist.

Subject of Research: The relationship between obesity awareness and anthropometric versus sociocultural factors in adults

Article Title: Is obesity awareness related to anthropometric measures or sociocultural factors?

Article References: Tikac, G., Altug, S. D., & Unal, A. (2026). Is obesity awareness related to anthropometric measures or sociocultural factors?. International Journal of Obesity. https://doi.org/10.1038/s41366-026-02238-5

Image Credits: AI Generated

DOI: 10.1038/s41366-026-02238-5

Keywords: obesity awareness, body mass index, waist-hip ratio, waist-to-height ratio, anthropometry, cross-sectional study, sociodemographic factors, occupational status, family history, public health, International Journal of Obesity, health literacy

The research, led by Anna Karin Hedström, Tomas Olsson, and Lars Alfredsson of Karolinska Institutet and published in the Journal of Neurology, drew on the Epidemiologic Investigation of Multiple Sclerosis, a population-based study that recruited newly diagnosed patients from 40 neurology units across Sweden, including every university hospital, between April 2005 and December 2021. Of 3,792 incident cases enrolled with a participation rate of 91 percent, the final analytic sample comprised 3,094 individuals after excluding those with uncertain family history or missing follow-up disability data. Each participant completed a structured questionnaire at inclusion covering demographics, environmental exposures, lifestyle factors, and family history of the disease.

Participants were sorted into three groups based on their closest affected relative: those with no known family history, those with a first-degree relative with multiple sclerosis, and those with a second- or third-degree relative with the disease. In total, 239 participants, or 7.7 percent, reported an affected first-degree relative, while 468, or 15.1 percent, reported an affected second- or third-degree relative. This hierarchical classification by degree of relatedness is a methodological strength, because many earlier studies lumped all familial cases together or relied on small clinic-based samples that could not disentangle the effects of relatedness from other prognostic factors.

The study then linked participants to the Swedish MS Registry, a nationwide resource integrated into routine clinical practice in which neurologists prospectively record disease activity, neurological function, and treatment exposure at every visit. Baseline was defined as the first available Expanded Disability Status Scale assessment, and the primary outcome was confirmed disability worsening, defined as a sustained increase of at least 1.0 EDSS point confirmed at a subsequent visit at least six months later, with adjustments for lower baseline scores. The researchers also tracked time to EDSS milestones 3 and 4, new or enlarging T2 lesions on MRI, cognitive decline on the Symbol Digit Modalities Test, and worsening on the patient-reported Multiple Sclerosis Impact Scale-29, capturing both physical and psychological dimensions of the disease.

Using Cox proportional hazards regression adjusted for age, sex, ancestry, education, calendar year of diagnosis, disease duration, baseline disability, smoking, body mass index, and initial disease-modifying therapy, the team found no significant associations between family history status and any of these outcomes. The hazard ratio for confirmed disability worsening was 1.06 among people with a first-degree relative with the disease and 1.04 among those with a second- or third-degree relative, with confidence intervals spanning unity in both cases. Separate analyses of relapse-associated worsening and progression independent of relapse activity, the two components of confirmed worsening, likewise showed no clear differences, and sensitivity analyses that modeled treatment as a time-varying covariate or reclassified participants with uncertain family history left the conclusions unchanged.

The negative findings extended across every domain examined. MRI disease activity, measured as the first appearance of new or enlarging T2 lesions, showed hazard ratios of 1.11 and 0.95 for the first-degree and second-/third-degree groups respectively. Cognitive worsening, defined as a drop of eight or more points on the Symbol Digit Modalities Test, yielded hazard ratios of 1.05 and 0.93, and a stricter four-point threshold produced similar results. Patient-reported worsening on both the physical and psychological subscales of the MSIS-29 was also unrelated to family history. Linear mixed-effects models tracking longitudinal change over time found no evidence that trajectories differed among the family history groups for cognition or for either patient-reported subscale, with interaction p-values ranging from 0.267 to 0.941.

One baseline difference did emerge: individuals with a first-degree relative with multiple sclerosis were significantly more likely to carry the HLA–DRB1*15:01 allele, the strongest genetic risk factor for the disease, with 68.3 percent positivity compared with 52.8 and 53.4 percent in the other groups. Beyond this, however, the groups were remarkably similar at disease onset. Age at onset, sex distribution, disease phenotype, smoking habits, body mass index, sun exposure, physical activity, Epstein-Barr virus antibody levels measured against the main MS-associated EBNA-1 peptide segment, and vitamin D levels showed no meaningful differences, suggesting that people with and without familial disease constitute clinically and epidemiologically comparable populations once the disease has declared itself.

The authors argue that this overall similarity points to a fundamental biological distinction between disease initiation and disease progression. Most of the more than 200 genetic susceptibility loci identified through genome-wide association studies relate to immune regulation and the risk of developing multiple sclerosis in the first place, not to how severe the disease becomes afterward. Familial clustering, on this view, primarily reflects shared predisposition to disease onset, while later progression is driven by other forces, including treatment exposure, aging, comorbidities, and lifestyle factors. A recent genome-wide association study published in Nature identified a severity locus implicating central nervous system resilience, underscoring that the genetics of progression may be largely separate from the genetics of susceptibility.

The researchers also acknowledge that family history is a blunt instrument. It does not capture the underlying burden or composition of genetic risk variants, and it conflates inherited factors with shared familial environment. Individuals classified as having familial disease may carry very different genetic risk profiles, while some people without a known affected relative may nonetheless harbor substantial inherited susceptibility. Such heterogeneity would tend to dilute any true association toward the null. Self-reported family history may also be incomplete, particularly for more distant relatives, introducing nondifferential misclassification. Yet the absence of any consistent gradient across degrees of relatedness in the sensitivity analyses argues against a hidden signal of clinically meaningful magnitude.

For patients and clinicians, the practical message is considerable. A family history of multiple sclerosis, which often looms large in the minds of newly diagnosed patients and their relatives, should not by itself be treated as a marker of worse prognosis or a reason to escalate therapy more aggressively. The study does not rule out modest effects, particularly among the comparatively small first-degree group, and the observational design leaves open the possibility of residual confounding by treatment decisions or unmeasured factors such as depression. But within the limits of a nationwide cohort with long-term follow-up, the conclusion is clear: inherited susceptibility shapes who develops multiple sclerosis, not how the disease unfolds once it has begun. The search for the determinants of progression must therefore look elsewhere, toward the emerging genetics of severity and the modifiable exposures that follow diagnosis.

Subject of Research: The prognostic impact of family history of multiple sclerosis on long-term disease outcomes

Article Title: Family history of multiple sclerosis and long-term outcomes

Article References: Hedström, A. K., Olsson, T., & Alfredsson, L. (2026). Family history of multiple sclerosis and long-term outcomes. Journal of Neurology, 273(10), Article 622. https://doi.org/10.1007/s00415-026-14162-9

Image Credits: AI Generated

DOI: 10.1007/s00415-026-14162-9

Keywords: multiple sclerosis, family history, disability progression, HLA-DRB1*15:01, genetic susceptibility, prognosis, MRI disease activity, cognitive decline, Swedish MS Registry, EIMS, relapsing-onset MS, epidemiology

The headline finding is striking: mammographic density, a measure of the amount of fibroglandular tissue visible on a mammogram relative to fatty tissue, accounts for 32.8 percent of the breast cancer burden among Malaysian women. That makes dense breasts the single largest contributor to the country’s breast cancer tally, outweighing every modifiable and hereditary factor examined in the study. The measurement matters because dense tissue both raises cancer risk independently and can mask tumors on mammographic images, complicating early detection in the very screening programs designed to catch the disease.

Among the factors that women and policymakers can actually change, elevated body mass index emerged as the leading contributor, responsible for 14.7 percent of the burden. Passive smoking accounted for another 8 percent. Together, these modifiable risks represent a substantial reservoir of preventable disease, and they respond to interventions ranging from weight management programs to smoke-free environment policies. The emphasis on passive smoking is particularly notable in Malaysia, where direct smoking rates among women have historically been low, but exposure to secondhand smoke in households and public spaces remains common.

Family history and genetic factors, which cannot be altered, collectively contributed 12.1 percent of the breast cancer burden. While this share is smaller than that of mammographic density, it remains clinically significant because inherited risk concentrates in identifiable families, making it a natural target for genetic counseling, testing programs, and intensified surveillance. The figure aligns with a growing body of work showing that hereditary factors, including pathogenic variants in established breast cancer risk genes, play a meaningful role in Asian populations just as they do in European-descended populations.

The methodology behind these estimates reflects a deliberate effort to ground the analysis in Malaysian realities rather than importing figures from Western cohorts. The researchers calculated population attributable risk using Malaysia-specific prevalence data drawn from national surveys, including the National Health and Morbidity Survey, and from local epidemiological studies. For the risk side of the equation, they used relative risks derived from meta-analyses of Asian prospective cohorts and case-control studies rather than relying on estimates from predominantly European populations. This dual commitment to local prevalence and Asian-specific effect sizes distinguishes the study from earlier attributable risk calculations in Japan, China, Korea, and Singapore that informed the broader literature.

Technically, the team estimated attributable proportions using Levin’s formula, a classic epidemiological expression that combines the prevalence of a risk factor in a population with the relative risk it confers. Because risk factors do not act in isolation, the researchers adjusted for the joint effects of multiple factors using a multiplicative model, the standard approach for combining independent risks without double counting. To attach uncertainty to the resulting estimates, they generated simulation-based confidence intervals, a technique that repeatedly resamples from the distributions of prevalence and relative risk to produce a robust range for each attributable fraction. The overall framework echoes the methods used in comparable national assessments, including studies of attributable cancer causes in Japan, Korea, China, and Singapore, but with prevalence inputs tailored specifically to Malaysian women.

One of the most consequential insights from the analysis is how the dominant risk factors shift across the life course. Reproductive factors, such as parity and related hormonal history, play a pronounced role in breast cancer occurring before menopause, whereas elevated body mass index predominates after menopause. This pattern is consistent with the biology of breast cancer. In premenopausal women, adipose tissue contributes relatively little to circulating estrogen compared with the ovaries, so reproductive history exerts a stronger influence. After menopause, when ovarian estrogen production ceases, fat tissue becomes the principal estrogen source, and excess body weight translates into elevated risk. The findings suggest that prevention messages should be age-calibrated: reproductive and lifestyle counseling for younger women, weight-focused interventions for older ones.

Ethnicity adds a further layer of complexity. Malaysia’s population comprises large Malay, Chinese, and Indian communities, and the study found that the impact of individual risk factors varies considerably across these groups. Mammographic density was most influential among Chinese women, while elevated body mass index played a greater role among Malays and Indians. This uneven distribution has practical implications for screening and prevention. Previous work by some of the same research groups has documented ethnic differences in mammographic density patterns across Asian populations, and the new attributable risk estimates translate those biological differences into consequences for the overall disease burden.

The authors argue that these findings support a balanced approach to breast cancer control that combines targeted prevention with risk-based early detection tailored to age and ethnic differences. In practice, that could mean prioritizing weight management and reducing secondhand smoke exposure as public health measures, while also building screening pathways that account for the high prevalence of dense breasts, particularly among Chinese Malaysian women. It also reinforces the case for personalized or risk-stratified screening, an approach championed in international consensus statements such as the ENVISION framework, in which screening intensity and modalities are matched to an individual’s composite risk profile rather than applied uniformly by age alone.

With breast cancer incidence climbing rapidly in Malaysia, the study fills a critical evidence gap. Large prospective studies in high-income countries have long enabled the estimation of preventable cancer cases and guided national cancer control strategies, but locally relevant data have been scarce for Malaysia. By quantifying the population-level contribution of mammographic density, lifestyle, reproductive, and hereditary factors with Malaysian-specific inputs, the research provides health authorities with a prioritized map of where prevention efforts can yield the greatest returns. A notable proportion of the country’s breast cancer burden, the analysis concludes, may be attributable to lifestyle and reproductive factors that are amenable to intervention, while genetic susceptibility and dense breast tissue also contribute importantly, demanding parallel investment in risk-based early detection.

Subject of Research: Population attributable risk of breast cancer from mammographic density, lifestyle, and hereditary factors in Malaysia

Article Title: Attributable breast cancer burden in Malaysia: mammographic density, lifestyle, and hereditary factors

Article References: Ang, B. H., Tai, M.-C., Farid, F. M., Ishak, I. S., Taib, M. F. M., Mariapun, S., Westerhout, C. J., Rahmat, K., Yip, C. H., Taib, N. A. M., Teo, S.-H., & Ho, W.-K. (2026). Attributable breast cancer burden in Malaysia: mammographic density, lifestyle, and hereditary factors. Cancer Causes & Control, 37(10), Article 170. https://doi.org/10.1007/s10552-026-02218-0

Image Credits: AI Generated

DOI: 10.1007/s10552-026-02218-0

Keywords: breast cancer, Malaysia, mammographic density, population attributable risk, body mass index, passive smoking, family history, genetic risk, reproductive factors, ethnic differences, cancer prevention, epidemiology